Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-01-02 00:00:00 ET · period of report 2025-12-31 · accession 0001193125-26-001181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-01-02 | 2025-12-31 | AXSM | Saad Mark E | Dir | M - OptEx | $5.46 | +37.6K | 41.3K | +996% | +$205.1K |
| DMT | 2026-01-02 | 2025-12-31 | AXSM | Saad Mark E | Dir | S - Sale+OE | $165.18 | -37.6K | 10.0K | -79% | -$6.21M |
| DMT | 2026-01-02 | 2025-12-31 | AXSM | Saad Mark E | Dir | M - OptEx | $0.00 | -37.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | M | A | 6,231 | $8.02 | 16,233 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-31 | S | D | 6,231 | $165.18 | 10,002 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $165.00 and $166.09. |
| 3 | Common | Common Stock | 2025-12-31 | S | D | 31,346 | $165.18 | 10,002 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $165.00 and $166.09. |
| 4 | Common | Common Stock | 2025-12-31 | M | A | 31,346 | $4.95 | 41,348 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-12-31 | M | D | 6,231 | $0.00 | 0 | D | $8.02 · 2017-05-27 to 2026-05-27 | 6,231 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-12-31 | M | D | 31,346 | $0.00 | 0 | D | $4.95 · 2018-03-15 to 2027-03-15 | 31,346 Common Stock |